[Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)]. 1979

K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
October 1977, Nihon Jinzo Gakkai shi,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
January 1979, Arzneimittel-Forschung,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
April 1978, Nihon Jinzo Gakkai shi,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
June 1976, Circulation research,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
October 1979, Endocrinologia japonica,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
June 1975, Clinical science and molecular medicine. Supplement,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
January 2002, Veterinary therapeutics : research in applied veterinary medicine,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
December 1976, Clinical science and molecular medicine. Supplement,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
K Nigawara, and Y Yagihashi, and T Kogawa, and A Kawamata, and K Yamaya, and S Sugawara, and Y Tulachan, and T Funyu, and H Eba, and K Kido, and T Tanaka, and S Morita, and M Fukushi, and M Furusawa, and Y Terayama, and N Hirayama
January 1975, Clinical nephrology,
Copied contents to your clipboard!